Lexicon Pharmaceuticals (LXRX) EPS (Basic) (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly EPS (Basic) of -$0.01 for Q1 2026, up 83.28% year-over-year from -$0.01 in Q1 2025, and up 71.42% quarter-over-quarter from -$0.05 in Q4 2025.
Powered by 
Analysis
Lexicon Pharmaceuticals (LXRX) EPS (Basic) (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported EPS (Basic) for 17 consecutive years, with -$0.01 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 83.28% year-over-year to -$0.01; the TTM figure through Mar 2026 stood at -$0.11 (up 79.66% YoY), while the FY2025 annual figure was -$0.17, up 91.36% from the prior year.
- EPS (Basic) improved to -$0.01 in Q1 2026 per LXRX's latest filing, from -$0.05 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.01 in Q2 2025 and bottomed at -$0.25 in Q2 2023.
- Historically, EPS (Basic) has averaged -$0.14 across 5 years, with a median of -$0.16 in 2022.
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 76.2% — and 2025, when it jumped 93.8%.
- Lexicon Pharmaceuticals' EPS (Basic) stood at -$0.16 in 2022, then sank by 54.54% to -$0.24 in 2023, then soared by 52.35% to -$0.11 in 2024, then surged by 59.51% to -$0.05 in 2025, then soared by 71.42% to -$0.01 in 2026.
- Business Quant data shows LXRX's EPS (Basic) at -$0.01 in Q1 2026, -$0.05 in Q4 2025, and -$0.05 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 0.18 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.06 |
| 10 | Lexicon Pharmaceuticals | 978.15 Mn | 787.54 Mn | 653,000.00 | -0.07 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.07 |
| Mar 31, 2026 | -0.01 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | -0.04 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.19 |
| Jun 30, 2024 | -0.19 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -0.23 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.19 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | -0.17 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | -0.18 |
| Sep 30, 2021 | -0.16 |